Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
ANXA3 encodes a member of the annexin family. Additionally we are shipping Annexin A3 Proteins (22) and Annexin A3 Kits (17) and many more products for this protein.
Showing 10 out of 153 products:
Horse (Equine) Polyclonal Annexin A3 Primary Antibody for IHC, WB - ABIN2774839
Sekar, Sambandam, Grizzle, McDonald: Dissociation of cyclic inositol phosphohydrolase activity from annexin III. in The Journal of biological chemistry 1996
Show all 5 Pubmed References
Human Monoclonal Annexin A3 Primary Antibody for RNAi, ELISA - ABIN559876
Cao, Ye, Zhang, Zhu, Wang, Yao: A multiplex model of combining gene-based, protein-based, and metabolite-based with positive and negative markers in urine for the early diagnosis of prostate cancer. in The Prostate 2011
Show all 2 Pubmed References
Human Monoclonal Annexin A3 Primary Antibody for IHC, WB - ABIN2453953
Pan, Pan, Weng, Zhao, Zhang, Wang, Lv, Jiang, Zheng, Xia: Annexin A3 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma. in Molecular carcinogenesis 2015
Show all 2 Pubmed References
Human Polyclonal Annexin A3 Primary Antibody for ICC, IF - ABIN4280815
Dinets, Pernemalm, Kjellin, Sviatoha, Sofiadis, Juhlin, Zedenius, Larsson, Lehtiö, Höög: Differential protein expression profiles of cyst fluid from papillary thyroid carcinoma and benign thyroid lesions. in PLoS ONE 2015
Human Polyclonal Annexin A3 Primary Antibody for IP, WB - ABIN1327266
Meadows, Cleaver: Annexin A3 Regulates Early Blood Vessel Formation. in PLoS ONE 2015
Annexin A3 regulates early blood vessel formation.
ANXA3 role in the proliferation and invasion of breast cancer cells.
Results identified potential variant in ANXA3 gene [chr4, c.C820T(p.R274*)] in a large family with an unknown equinus deformity, which could lead to a three-dimensional conformational change.
Anxa3 knockdown inhibited the growth, migration, invasion, and metastasis of lung adenocarcinoma.
These results suggest that the iEA index or a combination of polymorphisms in EGFR (show EGFR Antibodies) and ANXA3 may serve as predictive factors of drug response, and therefore could be useful for optimal selection of chemotherapy regimens.
ANX (show ANXA5 Antibodies) A3 has roles as a mammary biomarker, regulator and therapeutic target in breast cancer
Our results suggest that ANXA3 can serve as a novel diagnostic biomarker and that the inhibition of ANXA3 may be a viable therapeutic option for the treatment of CD133+ liver-CSC-driven HCC (show FAM126A Antibodies).
Findings reveal that ANXA3 might play an important role in hepatocellular carcinoma progression and chemoresistance.
findings suggest that ANXA3 plays a role in HCC (show FAM126A Antibodies) CSC/CIC (show CIC Antibodies) maintenance, and that ANXA3 may represent a potential CSC/CIC (show CIC Antibodies)-specific therapeutic target for improving the treatment of HCC (show FAM126A Antibodies).
Two different antigenic variants of ANXA3 are present in post-DRE (show SUFUH Antibodies) urines and their clinical significance for diagnosis of prostate cancer should be further investigated.
Urinary calreticulin (show CALR Antibodies), annexin A2 (show ANXA2 Antibodies), and annexin A3 are very likely a panel of biomarkers with potential value for upper tract urothelial carcinoma diagnosis.
data suggest that annexin A3 is a negative regulator of adipocyte differentiation
AnxA3 is not only endogenously expressed in mouse cortical neurons but more importantly, it is transcriptionally up-regulated with onset of lactacystin-mediated death in murine primary cortical neurons.
This gene encodes a member of the annexin family. Members of this calcium-dependent phospholipid-binding protein family play a role in the regulation of cellular growth and in signal transduction pathways. This protein functions in the inhibition of phopholipase A2 and cleavage of inositol 1,2-cyclic phosphate to form inositol 1-phosphate. This protein may also play a role in anti-coagulation.
, Annexin A3
, annexin A3-like
, annexin a3
, 35-alpha calcimedin
, Annexin III (lipocortin III)
, annexin III (lipocortin III, 1,2-cyclic-inositol-phosphate phosphodiesterase, placental anticoagulant protein III, calcimedin 35-alpha)
, calcimedin 35-alpha
, inositol 1,2-cyclic phosphate 2-phosphohydrolase
, lipocortin III
, placental anticoagulant protein III
, annexin III
, Annexin III (Lipocortin III)